Bio Medica Laboratories IPO Day 3 Subscription Status
By HDFC SKY | Published at: May 25, 2026 05:10 PM IST
Bio Medica Laboratories IPO Day 3 subscribed 2.25 times overall, with Retail 2.91x, NII 1.30x and QIB 15.94x as of May 25, 2026 4:25 PM.
Mumbai, May 25: Bio Medica Laboratories IPO received a steady response on Day 3, with the issue subscribed 2.25 times overall as of Monday.
The book-built issue aggregates ₹52.43 crore, comprising a fresh issue of 32.06 lakh shares worth ₹47.19 crore and an offer for sale of 3.77 lakh shares worth ₹5.24 crore. The IPO is priced in the band of ₹132 to ₹139 per share and closes today, May 25, 2026.
Bio Medica Laboratories IPO Day 3 Subscription Status
| Particulars | Details |
| Total Subscription | 2.25 times |
| QIB | 15.94 times |
| NII/HNI | 1.30 times |
| Retail | 2.91 times |
| Market Maker | 1.00 time |
| As of | May 25, 2026, 4:25 PM |
Category-wise Bio Medica Laboratories IPO Subscription Status
| Category | Subscription |
| QIB | 15.94x |
| NII/HNI | 1.30x |
| bNII | 0.86x |
| sNII | 2.19x |
| Retail | 2.91x |
| Market Maker | 1.00x |
| Total | 2.25x |
Bio Medica Laboratories Day-wise Subscription Summary
| Date | QIB | NII | Retail | Total |
| May 21, 2026 | 15.94x | 0.03x | 1.09x | 0.72x |
| May 22, 2026 | 15.94x | 0.28x | 1.42x | 1.01x |
| May 25, 2026 | 15.94x | 1.30x | 2.91x | 2.25x |
Bio Medica Laboratories IPO Timeline
| Event | Date |
| Issue Open Date | May 21, 2026 |
| Issue Close Date | May 25, 2026 |
| Basis of Allotment Date | May 26, 2026 |
| Initiation of Refunds | May 27, 2026 |
| Credit of Shares | May 27, 2026 |
| Listing Date | May 29, 2026 |
Brief Overview Of The IPO
| Particulars | Details |
| IPO Size | ₹52.43 crore |
| Fresh Issue | 32.06 lakh shares |
| Offer for Sale | 3.77 lakh shares |
| Price Band | ₹132 to ₹139 per share |
| Lot Size | 1,000 shares |
| Minimum Retail Investment | ₹2,78,000 |
| Minimum HNI Investment | ₹4,17,000 |
| Issue Type | Book-built issue |
| Listing At | NSE SME |
| Registrar | Skyline Financial Services Pvt. Ltd. |
| Lead Manager | Narnolia Financial Services Ltd. |
| Market Maker | Prabhat Financial Services Ltd. |
Bio Medica Laboratories, incorporated in August 2015, manufactures pharmaceutical parenteral formulations. Its product range includes liquid and dry-powder injectables for human and veterinary healthcare.
Source:
- https://www.nseindia.com/market-data/issue-information?symbol=BMLL&series=SME&type=Active
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Join Us
Add as preferred source on Google
